HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ADUS

Addus HomeCare Corporation (NASDAQ)

Healthcare — Medical Care Facilities

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Buy 1.6 / 5 13 analysts
$102.98
+$1.78 (+2.50%)
Target: $132.69 (28.9%)
Sign in to add ADUS to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$1.94B
P/E Ratio (TTM)19.13
Forward P/E13.88
EPS (TTM)$5.42
Dividend Yield-
Profit Margin6.89%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation Buy 1.6
Analyst Target$132.69
Analysts13
Indexes NASDAQ

Technical Indicators

RSI (14)88.7
Beta0.90
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume-
Volume-

Performance Analysis

NEUTRAL

ADUS presents a mixed picture with both positive and negative indicators.

- RSI at 88.7 indicates overbought conditions — a pullback may be due.
+ Wall Street consensus is "Buy" from 13 analysts.
+ Average analyst target of $132.69 implies 28.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 15:01 UTC

Back to Screener Export Report